Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV004724233 | SCV005333264 | pathogenic | not provided | 2024-02-02 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33268356, 35599849) |
Prevention |
RCV004731688 | SCV005338114 | uncertain significance | H3-3A-related disorder | 2024-04-11 | no assertion criteria provided | clinical testing | The H3-3A c.68C>T variant is predicted to result in the amino acid substitution p.Thr23Ile. This variant was reported in at least two individuals with Neurodegenerative disease and in at least one individual was this variant observed de novo (Figure 1 as T22I, Bryant et al 2020. PubMed ID: 33268356; Table 1, Elliott et al. 2022. PubMed ID: 35599849). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Although we suspect this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |